Private Wealth Asset Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Private Wealth Asset Management, LLC
- $695 Billion
- Q1 2025
A detailed history of Private Wealth Asset Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Wealth Asset Management, LLC holds 800 shares of CPRX stock, worth $17,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800Holding current value
$17,360% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$406 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$120 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$74.3 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$68 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.23B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...